The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 22, 2024
Filed:
Sep. 24, 2019
Takeda Pharmaceutical Company Limited, Osaka, JP;
Hiroshi Imoto, Fujisawa, JP;
Mari Adachi, Fujisawa, JP;
Yoko Kanematsu, Fujisawa, JP;
Taiji Asami, Fujisawa, JP;
Ayumu Niida, Fujisawa, JP;
Naoki Nishizawa, Fujisawa, JP;
Derek Cecil Cole, San Diego, CA (US);
Mack Flinspach, San Diego, CA (US);
Nick Scorah, San Diego, CA (US);
Abhijit Suresh Bhat, Cambridge, MA (US);
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Abstract
The present disclosure provides GIP receptor agonist peptide compounds having an activating action on GIP receptors and use of the GIP receptor agonist peptide as a medicament for the treatment and/or prevention of diabetes, obesity, emesis, or a symptom or condition associated with diabetes, obesity, or emesis. Specifically, a GIP receptor agonist peptide containing a sequence represented by the formula (I) or a salt thereof, and a medicament comprising the same are provided. Formula I: P-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-A41-P(SEQ ID NO: 4), or a salt thereof, wherein each symbol is as defined herein, with the proviso that the GIP receptor agonist peptide does not have an amino acid sequence as provided in SEQ ID NOs: 328-893.